Evidence map›Paper›PMID 33634736›Full record

ArticleEmerging microbes & infections2021

D Alvarez Martinez, C Alberto, A Riat, C Schuhler, P Valladares, B Ninet, B Kraak, P W Crous, L W Hou, L Toutous Trellu

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Mycobiology · 2026
    Article
  2. The First Case of Tenosynovitis Caused byAnnals of laboratory medicine · 2024
    Article
  3. MycoKeys · 2024
    Article
  4. Name Changes for Fungi of Medical Importance, 2020 to 2021.Journal of clinical microbiology · 2023
    Review
  5. MycoKeys · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

D Alvarez MartinezDivision of Dermatology and Venereology, University Hospital of Geneva, Genève, Switzerland.
C AlbertoDivision of Dermatology and Venereology, University Hospital of Geneva, Genève, Switzerland.
A RiatDivision of Laboratory Medicine, Laboratory of Bacteriology, University Hospital of Geneva, Genève, Switzerland.
C SchuhlerDivision of Dermatology and Venereology, University Hospital of Geneva, Genève, Switzerland.
P ValladaresDivision of Infectious Diseases, University Hospital of Geneva, Genève, Switzerland.
B NinetDivision of Laboratory Medicine, Laboratory of Dermatology, University Hospital of Geneva, Genève, Switzerland.
B KraakWesterdijk Fungal Biodiversity Institute, CT Utrecht, Netherlands.
P W CrousWesterdijk Fungal Biodiversity Institute, CT Utrecht, Netherlands.ORCID https://orcid.org/0000-0001-9085-8825
L W HouState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.
L Toutous TrelluDivision of Dermatology and Venereology, University Hospital of Geneva, Genève, Switzerland.ORCID https://orcid.org/0000-0001-8087-1161
University Hospital of Geneva · CHWesterdijk Fungal Biodiversity Institute · NLChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare or opportunistic fungal infections are mostly described in immunosuppressed patients. We present a case of a cutaneous phaeohyphomycosis that developed on the dorsal foot in an immunosuppressed woman suffering from AIDS, caused by a novel

Indexed as

Anti-Bacterial AgentsDNA, FungalFemaleFootHumansImmunocompromised HostMiddle AgedOpportunistic InfectionsPhaeohyphomycosisSaccharomycetalesSequence Analysis, DNAAnti-Bacterial AgentsDNA, Fungala new taxonBioavailability itraconazoledeep cutaneous phaeohyphomycosisimmunosuppressionopportunistic fungal infections

Identifiers

PMID33634736
PMCPMC7946049
OpenAlexW3131411035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.